Is Teva Pharmaceutical Industries Limited overvalued?

Teva Pharmaceutical Industries Limited (TEVA) looks undervalued — trading about 106% below its fair value.

Undervalued

Price

$36.58

Fair value

$75.43

Current P/E

12.5

Normal P/E

25.7

Market cap

$42.60B

Dividend yield

2.3%

Return on equity

9.1%

Sector

Healthcare

Fair value compares TEVA's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 13 Aug 2026.

Related stocks